First trial tests MS drug for rare, untreated spinal disease

NCT ID NCT04799288

Recruiting now Disease control Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a drug called teriflunomide, already used for multiple sclerosis, can help people with HAM/TSP—a rare, progressive disease that causes leg weakness and has no current treatment. Researchers will give the drug to 24 adults with HAM/TSP for 9 months to see if it is safe, reduces immune system activity linked to the disease, and improves symptoms. The goal is to find a way to control this debilitating condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAM/TSP are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Institutes of Health Clinical Center
RECRUITING

Bethesda, Maryland, 20892, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HAM/TSP